Apexigen, Inc. Proceeds from Stock Options Exercised
Apexigen, Inc. reported Proceeds from Stock Options Exercised of $0 for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2023-08-10
- Apexigen, Inc. proceeds from stock options exercised for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- Apexigen, Inc. proceeds from stock options exercised for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- Apexigen, Inc. proceeds from stock options exercised for the quarter ending 2022-12-31 was $0.00.
- Apexigen, Inc. proceeds from stock options exercised for the quarter ending 2022-09-30 was $37.00K.
- Apexigen, Inc. proceeds from stock options exercised for fiscal 2022 was $110.00K, a 12.24% increase from fiscal 2021.
- Apexigen, Inc. proceeds from stock options exercised for fiscal 2021 was $98.00K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $0.00 10-Q · filed 2023-08-10 | $0.00 derived: sum of 3 quarters · filed 2023-08-10 | $37.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-15 | $0.00 derived: sum of 2 quarters · filed 2023-05-15 | $37.00K derived: sum of 3 quarters · filed 2023-05-15 | $60.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $37.00K derived: sum of 2 quarters · filed 2023-02-22 | $60.00K derived: sum of 3 quarters · filed 2023-08-10 | $110.00K 10-K · filed 2023-02-22 |
| 2022-09-30 | $37.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $60.00K derived: sum of 2 quarters · filed 2023-08-10 | $110.00K 10-Q · filed 2022-11-14 | $109.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-06-30 | $23.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $73.00K 10-Q · filed 2023-08-10 | $72.00K derived: sum of 3 quarters · filed 2023-08-10 | |
| 2022-03-31 | $50.00K 10-Q · filed 2023-05-15 | $49.00K derived: sum of 2 quarters · filed 2023-05-15 | ||
| 2021-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $98.00K 10-K · filed 2023-02-22 | ||
| 2021-09-30 | $99.00K 10-Q · filed 2022-11-14 |